Skip to content
Shionogi
EntityQ3482319· pop 10· linked from 285 articles

Also known as Shionogi & Company, SHIONOGI & CO., LTD., Shionogi Seiyaku Kabushiki Kaisha, Shionogi Inc.

is a Japanese pharmaceutical company best known for developing Crestor. Medical supply and brand name also uses katakana (シオノギ).

Key facts

Company.name
Shionogi & Co., Ltd.
Company.type
Public (K.K)
Company.native_name
塩野義製薬株式会社
Company.native_name_lang
ja
Company.romanized_name
Shionogi Seiyaku Kabushiki Kaisha
Company.founder
Gisaburo Shiono Sr.
Company.foundation
Osaka, Japan ()
Company.num_employees
Consolidated : 6,082
Company.industry
Biotechnology & Pharmaceuticals
Company.traded_as
Nikkei 225 Component
Company.location
1-8, Doshomachi 3-chome, Chuo-ku, Osaka 541-0045, Japan
Company.logo
SHIONOGI Top-logo-03.png
Company.subsid
Shinogi HealthcareShinogi PharmaUMN Pharma
Company.revenue
¥ 426.684 billion (2022)
Company.operating_income
¥ 133.274 billion (2022)
Company.net_income
¥ 107.367 billion (2022)
Company.assets
¥ 768.120 billion (2022)
Company.equity
¥ 1,121.878 billion (2022)

via Wikipedia infobox

Research organization · ROR

Type
Company, Funder
Founded
1878
Location
Osaka, Japan
Also known as
Shionogi Seiyaku Kabushiki Kaisha
Status
Active

GRID grid.419164.f · ISNI 0000 0001 0665 2737

~3 min read

Encyclopedic overview

6 sections
Contents
  • Medicines
  • Released
  • Under development
  • Media
  • References
  • External links

is a Japanese pharmaceutical company best known for developing Crestor. Medical supply and brand name also uses katakana (シオノギ).

Shionogi has business roots that date back to 1878, and was incorporated in 1919. Among the medicines produced are for hyperlipidaemia, antibiotics, and cancer medicines.

Excerpted from Wikipedia’s “Shionogi” article, available under the CC BY-SA 4.0 licence.